Home » Topics » Regulatory

Regulatory
RSS

GSK seeks European approval of Seretide for COPD

Oct. 18, 2001

Foradil now cleared for use in COPD in the U.S.

Oct. 17, 2001

Health Canada approves enhanced labeling for Copaxone

Oct. 17, 2001

ODAC meeting rescheduled for early December

Oct. 17, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Biovail files NDA for FlashDose version of fluoxetine

Oct. 5, 2001

FDA approves Entocort EC for treatment of Crohn's disease

Oct. 5, 2001

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...